JDRF Blog
At ADA, JDRF-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
At the ADA’s Scientific Sessions, JDRF scientists presented on some of the most important topics, all with the same goal: Ending type 1 diabetes.
Read More About At ADA, JDRF-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
FDA Approved! Abbott FreeStyle Libre® 3 Continuous Glucose Monitor, Ages 4+
The FDA cleared the FreeStyle Libre 3 continuous glucose monitor (CGM) for children and adults ages 4 and up with diabetes
Read More About FDA Approved! Abbott FreeStyle Libre® 3 Continuous Glucose Monitor, Ages 4+
Helping the Diabetes Community in Ukraine - 6/1 Update
Guide on how to support the diabetes community in Ukraine.
Read More About Helping the Diabetes Community in Ukraine - 6/1 Update
100, 100: Ending Diabetic Eye Disease, Forever
JDRF has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of blindness by 95%.
Read More About 100, 100: Ending Diabetic Eye Disease, ForeverRecent Articles
Sign up for our monthly Research Newsletter, The Pipeline, to stay up to date on the latest and greatest in T1D science.
By clicking Sign Up, I agree to the JDRF Privacy Policy. I also agree to receive emails from JDRF and I understand that I may opt out of JDRF subscriptions at any time.